A GLP-1 receptor agonist medication that regulates appetite, slows gastric emptying, and improves insulin sensitivity — used for medical weight management and metabolic health optimization.
Semaglutide mimics the incretin hormone GLP-1, which is naturally released after eating. It acts on appetite centers in the brain to reduce hunger and food cravings, slows stomach emptying to increase satiety, and improves insulin sensitivity. When combined with nutrition counseling and exercise, it can produce significant, sustainable weight loss.
Patients with a BMI over 27 with metabolic comorbidities, or BMI over 30, who have not achieved weight goals through diet and exercise alone.
Book a free consultation to discuss how this treatment can help you achieve your health goals.